// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

An audit to assess the rate of physiotherapy referral and BASMI measurements for patients with ankylosing spondylitis in the general rheumatology clinic at Sheffield Teaching Hospitals

Mithun Chakravorty - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

N/A

A novel pathway for the management of patients referred with suspected giant cell arteritis

Rudrik N U Thakkar - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

N/A

Drug safety knowledge of patients receiving cyclophosphamide treatment on the rheumatology day care unit: an audit

Grant S Nolan - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Cyclophosphamide

An experience of tight control in psoriatic arthritis management within the Belfast Trust

Ashley Elliott - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

N/A

An audit on the use and response to secukinumab within the Belfast Trust

Ashley Elliott - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

secukinumab

Is biologic therapy for inflammatory joint disease effective in real life?

Lauren Steel - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

The management of biologics peri-operatively and post-operatively

Jean Zhang - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Audit of muscle biopsy pathway: proof of concept for a local service

Matthew Chak Hin Szeto - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Analysis of rheumatoid arthritis patients who failed the switch from originator etanercept to biosimilar etanercept in Croydon

Dimil Patel - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Etanercept

ACTH reborn: modernising the evidence

Muhammad K Nisar - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

High bone density: too much of a good thing?

Shyanthi Pattapola - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Renal osteodystrophy

Alkaline phosphatase

Two cases of thyroid myopathy

Babitha Mekkayil - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypothyroidism

N/A

A case of large saddle pulmonary embolism in a patient with giant cell arteritis

Ezolene P Chua - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Giant cell arteritis

N/A

Is the dose banding of infliximab cost effective? A real world study

Muhammad K Nisar - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Infliximab

Is pre-methotrexate folate measurement helpful in predicting methotrexate side effects and methotrexate survival?

Sharmaine Yen Ling Quake - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Methotrexate

Timely recognition and management of the hot joint in patients on biologic therapy

Medha Kanitkar - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The early inflammatory arthritis clinic: who do we see and can we predict biologic use?

Sameena Khalid - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Early inflammatory arthritis

N/A

Consultants, registrars and nurse specialists: how does their caseload compare? An analysis of a Midland rheumatology centre

Francis Kynaston-Pearson - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pulmonary function testing for patients initiating methotrexate for inflammatory arthritis

Philip Yee - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Methotrexate

Effect of reconfiguring existing resources into an early arthritis clinic model on access times and discharge rates: results from a quality improvement project

Joshua Newmark - British Society for Rheumatology (BSR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Copyright © 2026. QuantiNova All rights reserved